
Miguel E. Rentería
@mrenteria_
Group Leader, Computational Neurogenomics @QIMRB_Institute. Passionate about neurogenetics, data science, Parkinson’s disease & mentoring future scientists.
ID: 63055192
05-08-2009 06:36:46
1,1K Tweet
397 Followers
173 Following






What if the next Alzheimer's breakthrough isn't a new drug - but an old one? Nature Communications reveals AI/ big data are uncovering surprising treatments for AD. - Diabetes drugs - Asthma meds - Even Viagra Here's what they're uncovering and why you aren't hearing about this 🧵





Scientists Cell Press reviewed 408 YouTube clips of sleeping cats and found 2/3 curled up on their left side. Here’s the neuroscience behind why:🧵 (Please watch their video abstract I put on the last post - it’s 100% worth it)



"A large proportion of #Parkinsons diagnoses are wrong - here’s how #AI could help" - interesting interview with David Vaillancourt from UF College of Health & Human Performance jamanetwork.com/journals/jama/…

New perspective from the michaeljfox.org & collaborators outlines the Targets to Therapies (T2T) - a community-led initiative to de-risk & advance #Parkinsons therapeutic targets nature.com/articles/s4153…




A new study from the lab Nature Medicine Over 6,000 proteins, more than 10,500 individuals. #Alzheimers, #Parkinsons, and #FTD. Muhammad Ali maps the shared and disease-specific plasma proteomic landscape of neurodegeneration WashU Medicine Neurology nature.com/articles/s4159…




Congruence Therapeutics has been awarded a $5 M grant from michaeljfox.org to advance their novel GCase activators & correctors for #Parkinsons with GBA1 variants through lead optimization towards the clinic prnewswire.com/news-releases/…
